Molecular Research on Lung, Microbiome and Pulmonary Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Microbiology".
Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 9709
Special Issue Editor
2. Department of Human Sciences and Quality of Life Promotion San Raffaele University, Via di Val Cannuta, 247, I-00166 Rome, Italy
Interests: research in nicotinic receptor in cancer; COPD; addiction; Alzheimer; systems medicine; Covid-19
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Diseases of the respiratory system are among some of the most common medical conditions in the world. Tens of millions of people have lung disease in the U.S. alone. Moreover, diseases of the respiratory system accounted for 7.5 % of all deaths in the EU-27 in 2016. Smoking, infections, and genes cause most lung diseases. Pulmonary pathology includes a large spectrum of both neoplastic and non-neoplastic diseases (i.e., COPD) that affect the lung. Pulmonary pathology studies the changes in the lung tissues and the mechanisms through which these occur. Although, initially, the lung was considered sterile, actually, the existence of a healthy lung microbiome is usually accepted, and changes are reported in COPD and in its exacerbation. The lung is the main affected organ in severe coronavirus disease 2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2, and lung damage is the leading cause of death in the vast majority of patients. Post-mortem examinations of COVID-19 patients revealed diffuse alveolar damage with severe capillary congestion, microthrombosis, and thrombosis of small to mid-sized arteries as well as pulmonary thromboembolism, suggesting vascular dysfunction.
In this Special Issue, we invite contributors to publish their research on microbe-related lung diseases molecular biology, the molecular basis of pathogenicity, latent infection, immune evasion strategies, and the development of new vaccines.
Dr. Patrizia Russo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COPD
- cellular mechanism
- genetics
- lung cancer
- lung microbiota
- molecular mechanisms
- smoking
